OptimizeRx (OPRX) Earnings Analysis

OptimizeRx (OPRX) next reports earnings on 2026-08-06, consensus EPS 0.11 USD. Last quarter (2026-03-05) it beat with EPS 0.51 USD vs 0.23 USD est (+121.7%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 17.63.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does OPRX next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.11 USD
Revenue estimate0.02B

OPRX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-050.51 USD0.23 USD+121.7%Beat
2025-11-060.2 USD0.03 USD+566.7%Beat
2025-08-070.24 USD0.03 USD+700%Beat
2025-05-120.08 USD-0.11 USD+172.7%Beat
2025-03-120.3 USD0.25 USD+20%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

OPRX valuation and analyst view

Trailing P/E17.63
Trailing EPS0.36436 USD
Price / book0.94
Dividend yield0.00%
Market cap0.12B
Analyst consensusBuy (11 buy / 4 hold / 0 sell)
Avg price target10.5 USD

Related research pages

Frequently asked questions

When is OptimizeRx (OPRX)'s next earnings date?

OptimizeRx is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.11 USD and revenue estimate of 0.02B.

Did OPRX beat earnings last quarter?

In its 2026-03-05 report, OPRX posted EPS of 0.51 USD versus a 0.23 USD estimate — a beat of 121.7%.

What is OPRX's earnings track record?

Over the last 5 reported quarters with consensus data, OPRX beat estimates 5 times (100%).

What is OPRX's current P/E ratio and EPS?

OPRX trades at a trailing P/E of 17.63 on trailing EPS of 0.36436082125521985 USD.

What do analysts rate OPRX?

Analyst consensus is "Buy" across 15 ratings (0 strong buy, 11 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 10.5 USD.